Cargando…

Improved Transgenic Mouse Model for Studying HLA Class I Antigen Presentation

HLA class I (HLA-I) transgenic mice have proven to be useful models for studying human MHC-related immune responses over the last two decades. However, differences in the processing and presentation machinery between humans and mice may have profound effects on HLA-I restricted antigen presentation....

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Man, Zhang, Wei, Guo, Jie, Wei, Xundong, Phiwpan, Krung, Zhang, Jianhua, Zhou, Xuyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5025652/ https://www.ncbi.nlm.nih.gov/pubmed/27634283 http://dx.doi.org/10.1038/srep33612

Ejemplares similares

A Novel Transgenic Mouse Line for Tracing MicroRNA-155-5p Activity In Vivo
por: Phiwpan, Krung, et al.
Publicado: (2015)

MicroRNA-142-3p Negatively Regulates Canonical Wnt Signaling Pathway
por: Hu, Tanyu, et al.
Publicado: (2016)

Ex-TFRs: A Missing Piece of the SLE Puzzle?
por: Wei, Xundong, et al.
Publicado: (2021)

A Split-Cre system designed to detect simultaneous expression of two genes based on SpyTag/SpyCatcher conjugation and Split-GFP dimerization
por: Wei, Xundong, et al.
Publicado: (2021)

Determining if T cell antigens are naturally processed and presented on HLA class I molecules
por: Friedman, Jay, et al.
Publicado: (2022)

ROLE OF HLA CLASS-I ANTIGENS IN DELUSIONAL DISORDER
por: Debnath, Monojit, et al.
Publicado: (2000)

Functional interaction between human histocompatibility leukocyte antigen (HLA) class II and mouse CD4 molecule in antigen recognition by T cells in HLA-DR and DQ transgenic mice
Publicado: (1994)

HLA antigens in colorectal tumours--low expression of HLA class I antigens in mucinous colorectal carcinomas.
por: van den Ingh, H. F., et al.
Publicado: (1987)

Natural HLA Class I Polymorphism Controls the Pathway of Antigen Presentation and Susceptibility to Viral Evasion
por: Zernich, Danielle, et al.
Publicado: (2004)

Proteome Sampling by the HLA Class I Antigen Processing Pathway
por: Hoof, Ilka, et al.
Publicado: (2012)

Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics
por: Nagler, Adi, et al.
Publicado: (2021)

The association between chronic spontaneous urticaria and HLA class I and class II antigen
por: DOĞAN, Neslihan, et al.
Publicado: (2020)

Antigen presentation in SARS-CoV-2 infection: the role of class I HLA and ERAP polymorphisms
por: Saulle, Irma, et al.
Publicado: (2021)

HLA-DO and Its Role in MHC Class II Antigen Presentation
por: Poluektov, Yuri O., et al.
Publicado: (2013)

Cytotoxic T cell recognition of an endogenous class I HLA peptide presented by a class II HLA molecule
Publicado: (1990)

HLA class II transgenic mice: the chance to unravel the basis of HLA class II associations with disease
Publicado: (1994)

Direct evidence for binding of CD8 to HLA class I antigens
Publicado: (1989)

Human Leukocyte Antigen (HLA) class I and II datasets for sudanese
por: Dafalla, Ameer Mohamed, et al.
Publicado: (2019)

Endo-lysosomal assembly variations among human leukocyte antigen class I (HLA class I) allotypes
por: Olson, Eli, et al.
Publicado: (2023)

HLA-DP(84Gly) constitutively presents endogenous peptides generated by the class I antigen processing pathway
por: Yamashita, Yuki, et al.
Publicado: (2017)

Melanoma and Human Leukocyte Antigen (HLA): Immunogenicity of 69 HLA Class I Alleles With 11 Antigens Expressed in Melanoma Tumors
por: Georgopoulos, Apostolos P, et al.
Publicado: (2023)

Insights into the Role of GILT in HLA Class II Antigen Processing and Presentation by Melanoma
por: Norton, Duncan L., et al.
Publicado: (2009)

HLA-DO as the Optimizer of Epitope Selection for MHC Class II Antigen Presentation
por: Poluektov, Yuri O., et al.
Publicado: (2013)

Expression of classical human leukocyte antigen class I antigens, HLA‐E and HLA‐G, is adversely prognostic in pancreatic cancer patients
por: Hiraoka, Nobuyoshi, et al.
Publicado: (2020)

Tumour‐associated antigenic peptides are present in the HLA class I ligandome of cancer cell line derived extracellular vesicles
por: Kumar, Pankaj, et al.
Publicado: (2022)

HLA-A, B (Class I) and HLA-DR, DQ (Class II) Antigens in Turkish Patients with Recurrent Aphthous Ulceration and Behçet's Disease
por: Pekiner, Filiz Namdar, et al.
Publicado: (2013)

Differential effect of HLA class-I versus class-II transgenes on human T and B cell reconstitution and function in NRG mice
por: Majji, Sai, et al.
Publicado: (2016)

Alterations in HLA Class I-Presented Immunopeptidome and Class I-Interactome upon Osimertinib Resistance in EGFR Mutant Lung Adenocarcinoma
por: Qi, Yue A., et al.
Publicado: (2021)

Multiple Defects Impair the HLA Class II Antigen Presentation Capacity of Burkitt Lymphoma
por: God, Jason M., et al.
Publicado: (2016)

Potential Role of HLA Class I Antigens in the Glycolytic Metabolism and Motility of Melanoma Cells
por: Peppicelli, Silvia, et al.
Publicado: (2019)

c-Myc and EBV–LMP1: two opposing regulators of the HLA class I antigen presentation machinery in epithelial cells
por: Tudor, C S, et al.
Publicado: (2012)

Diversity of Natural Self-Derived Ligands Presented by Different HLA Class I Molecules in Transporter Antigen Processing-Deficient Cells
por: Lorente, Elena, et al.
Publicado: (2013)

Interaction between ERAP Alleles and HLA Class I Types Support a Role of Antigen Presentation in Hodgkin Lymphoma Development
por: Jiang, Peijia, et al.
Publicado: (2021)

PAKC: A novel panel of HLA class I antigen presentation machinery knockout cells from the same genetic origin
por: de Waard, Antonius A., et al.
Publicado: (2021)

BSBM-16 HLA CLASS-I ANTIGEN PRESENTATION MACHINERY AND IFN-γ PATHWAY ALTERATIONS IN LUNG CANCER BRAIN METASTASES
por: Vilarino, Noelia, et al.
Publicado: (2023)

CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence
por: Petrie, Emma J., et al.
Publicado: (2008)

Involvement of autophagy in MHC class I antigen presentation
por: Øynebråten, Inger
Publicado: (2020)

HLA-Class II Artificial Antigen Presenting Cells in CD4(+) T Cell-Based Immunotherapy
por: Couture, Alexandre, et al.
Publicado: (2019)

Single-cell derived tumor organoids display diversity in HLA class I peptide presentation
por: Demmers, Laura C., et al.
Publicado: (2020)

Autoreactive T cell clones specific for class I and class II HLA antigens isolated from a human chimera
Publicado: (1988)

Cannot write session to /tmp/vufind_sessions/sess_j8s1no5pdenc2p7vgeh5hpt94g